[vc_row][vc_column][vc_column_text]The global pharmaceutical service provider EarlyHealth Group joined the Advisory Platform of Life Sciences Manufacturers, Pharma.Aero’s hub of pharmaceutical companies providing support to projects and initiatives.
For the past four decades, EHG has collaborated with biotech, pharmaceutical companies and CROs in delivering a spectrum of clinical trial services and managed access solutions in more than sixty countries. With over 40 companies within the group, EHG is committed to improving the downstream of the life sciences industry, ensuring patients early access to medication. Their dedication to innovation and commitment to improving patient access to healthcare make them a valuable addition to our community.[/vc_column_text][vc_ph_quote voornaam=”Yulia Celetaria, Head of Logistics, EarlyHealth Group” quote=”We are excited to announce our partnership with Pharma.Aero and our participation in the Life Science Manufacturers Advisory platform as part of our continued commitment to enhancing supply chain logistics in the pharmaceutical industry. EarlyHealth Group (EHG) has a strong track record of providing comprehensive clinical trial services and managed access solutions to biotech, pharmaceutical, and CRO customers. By collaborating with Pharma.Aero and joining the Life Science Manufacturers Advisory platform, we aim to drive innovation and transformation in supply chain management, ultimately improving access to essential healthcare solutions. Together, we look forward to creating impactful change in advancing the delivery of healthcare services to patients worldwide, as well as bringing positive impact to the healthcare ecosystem.” foto=”12261″][vc_column_text]By signing up for the LMAP, EHG joins a select group of industry leaders within the Life Sciences Manufacturers Advisory Platform: MSD, Pfizer, Zoetis, Novartis, Bayer, Astra Zeneca’s Alexion, GSK, Johnson & Johnson, Euromed Pharma, Galapagos, and Germinare.
Pharma.Aero created the Life Science Manufacturers Advisory Platform (LMAP) to further engage the manufacturing segment to provide first-line advice on the activities and projects of Pharma.Aero and support the logistics and supply chain industry. The LMAP integrates into all Pharma.Aero cross-industry initiatives and provide content value to the organization.[/vc_column_text][/vc_column][/vc_row]